The Influence of Personalised Sarcoma Care (PERSARC) Prediction Modelling on Clinical Decision Making in a Multidisciplinary Setting

Table 3

Estimated and calculated OS and LR for each case with and without PERSARC.

Case	Treatment proposal	OS/LR MDT estimation (%)		OS/LR PERSARC prognosis (%)		∆ prognosis (∆—% absolute)
		OS	LR	OS	LR	∆OS	∆LR
1	R1	92.5	30.0	74.2	22.8	18.3	7.2
4	Neoadjuvant RT, R1	82.5	5.0	41.1	15.8	41.4	−10.8
6	Neoadjuvant RT, R1	27.5	20.0	14.0	20.4	13.5	−0.4
7	Neoadjuvant RT, R1	70.0	12.5	55.4	13.6	14.6	−1.1
8	R0	20.0	17.5	25.9	13.1	−5.9	4.4
9	Neoadjuvant RT, R1	40.0	15.0	77.0	10.0	−37.0	5.0
10	Neoadjuvant RT, R2	65.0	17.5	71.7	15.3	−6.7	2.2
13	Neoadjuvant RT, R1	82.5	5.0	72.7	10.9	9.8	−5.9
14	Neoadjuvant RT, R2	57.5	22.5	29.9	24.3	27.6	−1.8
15	Neoadjuvant RT, R0	65.0	17.5	81.3	2.9	−16.3	14.6
16	Neoadjuvant RT, R0	80.0	5.0	71.1	5.0	8.9	0.0
17	Neoadjuvant RT, R1	82.5	12.5	80.4	8.7	2.1	3.8
18	Neoadjuvant RT, R0	72.5	7.5	76.7	4.4	−4.2	3.1
19	R0	70.0	45.0	54.7	13.9	15.3	31.1
20	Neoadjuvant RT, R0	72.5	10.0	79.0	2.3	−6.5	7.7
21	Neoadjuvant RT, R0	80.0	5.0	77.0	4.8	3.0	0.2
22	Neoadjuvant RT, R0	75.0	10.0	57.6	6.6	17.4	3.4
23	Neoadjuvant RT, R1	62.5	12.5	49.2	10.0	13.3	2.5
24	R1, adjuvant RT	17.5	55.0	37.1	29.9	−19.6	25.1
25	Neoadjuvant RT, R1	40.0	22.5	70.7	7.8	−30.7	14.7
26	Neoadjuvant RT, R1	60.0	20.0	79.7	9.3	−19.7	10.7
27	Neoadjuvant RT, R1	60.0	10.0	71.8	10.0	−11.8	0.0
28	R2	12.5	100.0	28.9	27.3	−16.4	72.7
29	Neoadjuvant RT, R0	65.0	10.0	41.8	4.9	23.2	5.1
30	Neoadjuvant RT, R1	15.0	30.0	44.0	10.2	−29.0	19.8
31	Neoadjuvant RT, R0	85.0	10.0	77.9	3.0	7.1	7.0
32	R2	5.0	30.0	17.1	52.8	−12.1	−22.8
33	Neoadjuvant RT, R1	20.0	20.0	53.1	12.9	−33.1	7.1
34	Neoadjuvant RT, R1	35.0	25.0	59.4	9.4	−24.4	15.6
35	Neoadjuvant RT, R0	60.0	10.0	66.6	5.5	−6.6	4.5
36	Neoadjuvant RT, R0	65.0	10.0	79.9	4.3	−14.9	5.7

RT: radiotherapy.